Drug Distribution

Sep 18, 2016 by in PHARMACY Comments Off on Drug Distribution

Fig. 4.1 A schematic diagram showing the flow of solutes from blood to surrounding fluids and tissue-cells. Drug A, being more lipid soluble than Drug B, enters both interstitial (ISF)…

read more

Oxygen as a Drug

Sep 18, 2016 by in PHARMACY Comments Off on Oxygen as a Drug

Fig. 28.1 ATP output from a mole of glucose is different in the presence or absence of oxygen at the cellular level So, energy (ATP) requirements, and therefore oxygen requirements,…

read more

Drug Elimination

Sep 18, 2016 by in PHARMACY Comments Off on Drug Elimination

Phase I reactions add or unmask functional groups (e.g., –OH, −NH2, −SH, −COOH, etc.), which can then participate in phase II reactions. These are non-synthetic reactions. Oxidation reactions occur mainly…

read more

Drugs for the Management of Pain

Sep 18, 2016 by in PHARMACY Comments Off on Drugs for the Management of Pain

Fig. 18.1 The pain pathway and sites of action of analgesic drugs Non-steroidal anti-inflammatory drugs (NSAIDS) and local anesthetics (LA) are effective at the periphery where transduction of pain signals…

read more

Steady-State Principles

Sep 18, 2016 by in PHARMACY Comments Off on Steady-State Principles

Fig. 6.1 Achieving steady state with the use of: (A) a constant infusion (B) intermittent bolus dosing (C) an initial loading dose followed by intermittent doses A single bolus dose…

read more

The Septic Patient

Sep 18, 2016 by in PHARMACY Comments Off on The Septic Patient

Modified with permission from Wolters Kluwer Health; Antibiotic therapy in patients with septic shock. Eur J Anaesthesiol. 2011;28(5):318–24 Local and unit-specific antimicrobial guidelines need to be constructed after considering the…

read more

Drugs and the Endocrine System

Sep 18, 2016 by in PHARMACY Comments Off on Drugs and the Endocrine System

Permission from Hermansen, K. Insulin and new insulin analogues, insulin pumps and inhaled insulin in type 1 diabetes, in Pharmacotherapy of Diabetes: New development (eds: Mogensen, C) Springer 2007 New…

read more

The Bleeding Patient

Sep 18, 2016 by in PHARMACY Comments Off on The Bleeding Patient

Fig. 24.1 Primary hemostasis, secondary hemostasis and the fibrinolytic pathway. FDP – fibrin degradation products Table 24.1 Causes of bleeding disorders Management of Haemorrhage In treating the acutely bleeding patient,…

read more

Dose Response Relationship

Sep 18, 2016 by in PHARMACY Comments Off on Dose Response Relationship

Note: G-protein-coupled receptors are also called metabotropic receptors The basic concept of drug-receptor (receptor is used loosely to mean the binding target) interaction can be described by the lock-and-key model,…

read more

The Obstetric Patient

Sep 18, 2016 by in PHARMACY Comments Off on The Obstetric Patient

Drugs Used During Pregnancy and Delivery Care providers use many drugs for different purposes during pregnancy and delivery. There are some drugs that are used to aid with the delivery…

read more
Get Clinical Tree app for offline access